Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaResection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology
- Where
- Shanghai
- People
- 30
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07466810 - No phaseTaking peopleNurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology
- Where
- Shanghai
- Életkor
- Up to 18 év
- People
- 120
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT05306509 - 2. fázisTaking peopleStudy of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
- Where
- Suzhou
- Életkor
- 15 év and over
- People
- 28
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05376111 - 3. fázisTaking peopleCapizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
- Where
- Chengdu, Shanghai
- Életkor
- 12 hónap to 18 év
- People
- 200
- Run by
- Children's Cancer Group, China
See details and how to joinNCT05681260 - 2/3. fázisTaking peopleBrentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
- Where
- Shanghai
- Életkor
- 2 év to 35 év
- People
- 96
- Run by
- Children's Cancer Group, China
See details and how to joinNCT06563245 - No phaseNot yet taking people in KínaHEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
- Where
- Hangzhou, Ningbo
- Életkor
- 1 év to 21 év
- People
- 400
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07483749 - 1. fázisTaking peopleBY002 IIT Study in R/R Acute Leukemia
- Where
- Suzhou
- Életkor
- 16 év and over
- People
- 18
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07270770 - 1/2. fázisTaking peopleApatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 56
- Run by
- Peking University People's Hospital
See details and how to joinNCT07479732 - No phaseTaking peopleStandardized Nutritional Management of Pediatric Patients With Solid Tumors
- Where
- Shanghai
- Életkor
- Up to 18 év
- People
- 400
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT06730204 - Korai 1. fázisTaking peopleA Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults
- Where
- Wuhan
- Életkor
- 12 év to 75 év
- People
- 18
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470073 - 1/2. fázisTaking peopleCD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 1 év to 70 év
- People
- 54
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06316856 - No phaseTaking peopleClinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
- Where
- Beijing
- Életkor
- 1 év to 70 év
- People
- 353
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06343090 - No phaseTaking peopleIntegrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
- Where
- Wuhan
- People
- 1500
- Run by
- Shu Peng
See details and how to joinNCT07354295 - No phaseNot yet taking people in KínaNUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy
- Where
- Hangzhou
- Életkor
- 1 év to 18 év
- People
- 110
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07462299 - 1. fázisTaking peopleSafety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial
- Where
- Beijing
- Életkor
- 1 év to 18 év
- People
- 48
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06326008 - 2. fázisNot yet taking people in KínaLiposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS
- Where
- Hangzhou
- Életkor
- 14 év and over
- People
- 24
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07457775 - No phaseTaking peopleConstruction of AI Model for Precision Imaging Diagnosis of Cranial Diseases
- Where
- Wuhan
- People
- 1000
- Run by
- Tongji Hospital
See details and how to joinNCT07446842 - 2. fázisNot yet taking people in KínaIFN-α in Relapse Prevention.
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 100
- Run by
- Peking University People's Hospital
See details and how to joinNCT07449286 - No phaseTaking peopleClinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
- Where
- Hangzhou
- People
- 2000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07252986 - No phaseTaking peopleRW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
- Where
- Shanghai
- Életkor
- 14 év to 80 év
- People
- 80
- Run by
- Fudan University
See details and how to joinNCT06524167 - 3. fázisTaking peopleSelective Neck Dissection Versus Modified Neck Dissection in PTC
- Where
- Shanghai
- Életkor
- 14 év to 80 év
- People
- 250
- Run by
- Fudan University
See details and how to joinNCT06554652 - 3. fázisTaking peopleAdjuvant Radiotherapy in High Risk Locally Advanced DTC
- Where
- Shanghai
- Életkor
- 14 év to 80 év
- People
- 124
- Run by
- Fudan University
See details and how to joinNCT06558981 - 3. fázisTaking peopleCD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
- Where
- Beijing
- Életkor
- 3 év to 79 év
- People
- 70
- Run by
- Peking University People's Hospital
See details and how to joinNCT07441291 - No phaseTaking peoplePrimary Tumor Research and Outcomes Network
- Where
- Beijing
- People
- 1350 worldwide
- Run by
- AO Innovation Translation Center
See details and how to joinNCT02790983 - No phaseTaking peopleCIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
- Where
- Beijing
- Életkor
- 1 év to 39 év
- People
- 213
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06389305